Literature DB >> 14667502

Wnt5a inhibits B cell proliferation and functions as a tumor suppressor in hematopoietic tissue.

Huiling Liang1, Qin Chen, Andrew H Coles, Stephen J Anderson, German Pihan, Allan Bradley, Rachel Gerstein, Roland Jurecic, Stephen N Jones.   

Abstract

Wnt5a is a member of the Wnt family of secreted glycoproteins that play essential organizing roles in development. Similar to other Wnt members, Wnt5a can upregulate cell proliferation and has been proposed to have oncogenic function. Here we report that Wnt5a signals through the noncanonical Wnt/Ca++ pathway to suppress cyclin D1 expression and negatively regulate B cell proliferation in a cell-autonomous manner. Wnt5a hemizygous mice develop myeloid leukemias and B cell lymphomas that are clonal in origin and display loss of Wnt5a function in tumor tissues. Furthermore, analysis of human primary leukemias reveals deletion of the WNT5A gene and/or loss of WNT5A expression in a majority of the patient samples. These results demonstrate that Wnt5a suppresses hematopoietic malignancies.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14667502     DOI: 10.1016/s1535-6108(03)00268-x

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  128 in total

1.  Genome-wide miRNA profiling of mantle cell lymphoma reveals a distinct subgroup with poor prognosis.

Authors:  Javeed Iqbal; Yulei Shen; Yanyan Liu; Kai Fu; Elaine S Jaffe; Cuiling Liu; Zhongfeng Liu; Cynthia M Lachel; Karen Deffenbacher; Timothy C Greiner; Julie M Vose; Sharathkumar Bhagavathi; Louis M Staudt; Lisa Rimsza; Andreas Rosenwald; German Ott; Jan Delabie; Elias Campo; Rita M Braziel; James R Cook; Raymond R Tubbs; Randy D Gascoyne; James O Armitage; Dennis D Weisenburger; Timothy W McKeithan; Wing C Chan
Journal:  Blood       Date:  2012-04-05       Impact factor: 22.113

Review 2.  Wnt signaling and injury repair.

Authors:  Jemima L Whyte; Andrew A Smith; Jill A Helms
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-08-01       Impact factor: 10.005

3.  Wnt-mediated regulation of chondrocyte maturation: modulation by TGF-beta.

Authors:  Yufeng Dong; Hicham Drissi; Mo Chen; Di Chen; Michael J Zuscik; Edward M Schwarz; Regis J O'Keefe
Journal:  J Cell Biochem       Date:  2005-08-01       Impact factor: 4.429

4.  Induced mitotic recombination of p53 in vivo.

Authors:  Wei Wang; Madhuri Warren; Allan Bradley
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

5.  Paracrine WNT5A Signaling Inhibits Expansion of Tumor-Initiating Cells.

Authors:  Nicholas Borcherding; David Kusner; Ryan Kolb; Qing Xie; Wei Li; Fang Yuan; Gabriel Velez; Ryan Askeland; Ronald J Weigel; Weizhou Zhang
Journal:  Cancer Res       Date:  2015-03-13       Impact factor: 12.701

6.  Wnt-1 signal induces phosphorylation and degradation of c-Myb protein via TAK1, HIPK2, and NLK.

Authors:  Chie Kanei-Ishii; Jun Ninomiya-Tsuji; Jun Tanikawa; Teruaki Nomura; Tohru Ishitani; Satoshi Kishida; Kenji Kokura; Toshihiro Kurahashi; Emi Ichikawa-Iwata; Yongsok Kim; Kunihiro Matsumoto; Shunsuke Ishii
Journal:  Genes Dev       Date:  2004-04-01       Impact factor: 11.361

7.  WNT5A expression in ameloblastoma and its roles in regulating enamel epithelium tumorigenic behaviors.

Authors:  Waleerat Sukarawan; Darrin Simmons; Cynthia Suggs; Kimberly Long; J Timothy Wright
Journal:  Am J Pathol       Date:  2009-12-11       Impact factor: 4.307

8.  Canonical Wnt pathway signaling suppresses VCAM-1 expression by marrow stromal and hematopoietic cells.

Authors:  Sachin Malhotra; Paul W Kincade
Journal:  Exp Hematol       Date:  2008-10-25       Impact factor: 3.084

9.  Non-canonical WNT5A signaling up-regulates the expression of the tumor suppressor 15-PGDH and induces differentiation of colon cancer cells.

Authors:  Lubna M Mehdawi; Chandra Prakash Prasad; Roy Ehrnström; Tommy Andersson; Anita Sjölander
Journal:  Mol Oncol       Date:  2016-08-01       Impact factor: 6.603

Review 10.  WNT signalling pathways as therapeutic targets in cancer.

Authors:  Jamie N Anastas; Randall T Moon
Journal:  Nat Rev Cancer       Date:  2013-01       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.